Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.

[1]  T. van der Poll,et al.  Bidirectional Relation Between Inflammation and Coagulation , 2004, Circulation.

[2]  B. Jilma,et al.  Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia , 2004, Critical care medicine.

[3]  N. Mackman,et al.  Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. , 2004, Critical care medicine.

[4]  N. Mackman,et al.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. , 2004, Blood.

[5]  C. Dempfle.  Coagulopathy of sepsis , 2004, Thrombosis and Haemostasis.

[6]  J. Yélamos,et al.  Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. , 2004, Nucleic acids research.

[7]  J. Dhainaut,et al.  Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. , 2003, Blood.

[8]  M. Levi,et al.  Infection and inflammation and the coagulation system. , 2003, Cardiovascular research.

[9]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[10]  B. Zehnbauer,et al.  A META‐ANALYSIS OF CONTROLLED TRIALS OF ANTICOAGULANT THERAPIES IN PATIENTS WITH SEPSIS , 2003, Shock.

[11]  P. Carmeliet,et al.  Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. , 2003, Blood.

[12]  T. Iba,et al.  [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[13]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[14]  Z. Berente,et al.  Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. , 2003, Biochemical pharmacology.

[15]  D. Morel,et al.  Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model , 2002, Critical care medicine.

[16]  J. Hansen,et al.  Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation. , 2002, The Journal of infectious diseases.

[17]  C. Szabó,et al.  The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.

[18]  F. Gallyas,et al.  Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents* , 2002, Critical care medicine.

[19]  É. Szabó,et al.  Resistance to Acute Septic Peritonitis in Poly(ADP-ribose) Polymerase-1-Deficient Mice , 2002, Shock.

[20]  M. Nishimura,et al.  Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. , 2002, Blood.

[21]  T. van der Poll,et al.  Regulatory role of cytokines in disseminated intravascular coagulation. , 2001, Seminars in thrombosis and hemostasis.

[22]  Jeffrey I. Weitz,et al.  Characterization of a Mouse Model for Thrombomodulin Deficiency , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Norbert Lehn,et al.  Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in Mice , 2001, Infection and Immunity.

[24]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[25]  D. Inthorn,et al.  The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure. , 2000, Shock.

[26]  E. Faist,et al.  Coagulation inhibitor replacement during sepsis: Useless? , 2000, Critical care medicine.

[27]  R. Andriantsitohaina,et al.  Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.

[28]  R. Hotchkiss,et al.  Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.

[29]  J. Paramo,et al.  Effect of the administration of recombinant hirudin and/or tissue‐plasminogen activator (t‐PA) on endotoxin‐induced disseminated intravascular coagulation model in rabbits , 1999, British journal of haematology.

[30]  P. Chambon,et al.  Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. van der Poll,et al.  Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. , 1997, Blood.

[32]  T. van der Poll,et al.  Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. , 1997, Journal of immunology.

[33]  M. Elkjaer,et al.  Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. , 1997, Blood.

[34]  T. van der Poll,et al.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees , 1994, The Journal of experimental medicine.

[35]  T. Kensler,et al.  Myeloperoxidase as a biomarker of skin irritation and inflammation. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  T. van der Poll,et al.  Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. , 1994, Blood.

[37]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[38]  C. Esmon,et al.  DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. , 1991, Blood.

[39]  F. Taylor,et al.  A model for thrombin protection against endotoxin. , 1984, Thrombosis research.

[40]  W. Bode,et al.  Inflammation, sepsis, and coagulation. , 1999, Haematologica.